Using cutting-edge genomics technology, UVA Cancer Center researchers uncover patterns of chromatin accessibility in early gut development and reveal critical drivers of gut-related cancers.
Category: Gastroenterology Innovations
A clinical trial evaluating a novel nanoparticle drug may offer patients with primary biliary cholangitis the opportunity for a cure.
At UVA Health, GI/hepatology specialists and interventional radiologists collaborate to widen the range of treatment options for gastric varices.
Racial disparities in colon cancer rates occur due to how the colon's different sides age. Current research analyzes why.
Sacral nerve stimulation utilizes a small, pacemaker-like device to deliver electrical impulses that stimulate the sacral nerve.